CME Information

Course Overview Program Director Educational Objectives

Target Audience Method of Participation Accreditation Statement Term of Approval

Peer Review Disclaimer Disclosure Acknowledgement of Support

Course Overview

American adolescents are less likely to become pregnant now than a decade ago. However, the repercussions of unprotected adolescent sexual activity still pose a major public health problem in the United States. In 2005the National Vital Statistics Reports from the Center for Disease Control and Prevention (CDC), indicated that the pregnancy rate was 37/1000 15-19 year olds;  this corresponded to 295,000 births to young women this  age. The CDC’s 2005 Youth Risk Behavior Survey reported that 6% of high school students had sexual experience before they were 13 years of age, more than 60% of high school seniors had had intercourse, 52% were currently sexually active, and 20% had had at least four partners.

To address this national concern, this monograph provides recommendations for conducting an initial gynecologic health visit with an adolescent girl who is actively seeking contraception. The aim of is to help clinicians orchestrate a visit which ensures that the adolescent chooses a contraceptive method that is acceptable to her and commensurate with her ability to use it consistently and correctly. In addition to providing recommendations for a structured 30- to 45-minute initial gynecologic health visit, this monograph addresses adolescent development, patient confidentiality, techniques for involving parents and obtaining information about health risk behavior and substance abuse during the course of a medical and reproductive health history.

Educational Objectives

At the conclusion of this activity, the participant should be able to:

• Interview the patient for her risk behaviors as they relate to contraception and gynecologic care

• Determine the appropriate tests required in order to provide contraception

• Counsel a patient who is ambivalent about using contraception

• Counsel a patient who is ambivalent about using contraception

Target Audience

back to top

This CME activity is designed to meet the educational needs of OB/GYN physicians, family physicians, internists, pediatricians, nurse practitioners, and other heath care providers involved in women’s health issues.

Method of Participation

This activity is a monograph in prtable document format (PDF). References are linked to PubMed abstracts.

To receive a certificate you should:

• View the presentations in this CME activity and evaluate the content presented

• Complete and submit the posttest, CME registration and activity evaluation forms

The estimated time to complete this activity, including review of the materials, is 1.0 hour(s).

Accreditation/Credit Designation

back to top

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Baylor College of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.    

ACCME accredited providers may issue credit to both U.S. and international physicians for any activity that has been designated for AMA PRA Category 1 Credit(s)™ in accordance with PRA requirements.

Nursing credit approved: July 10, 2007

This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health for 0.5 contact hours of continuing education credit including 0.5 pharmacology contact hours.
Offering no. 06-28Y.

Term of Approval

August 2007 through August 2008. Original release date: August 2007

Peer Review

back to top

In April 2007, this continuing medical education activity was peer reviewed by Paula Amato, MD, associate professor, Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon. In order to ensure the continued scientific relevance of this enduring material, it will be reviewed again in August 2008.

Program Director

back to top

Paula Amato, MD
Associate Professor
Department of Obstetrics & Gynecology
Oregon Health & Science University
Portland, Oregon

Disclosure: nothing to disclose.

Alfred N. Poindexter, III, MD
Professor, Department of Obstetrics and Gynecology
Director, Division of Contraceptive Research and Development
Director, Gynecological Services, Baylor Population Program
Baylor College of Medicine
Houston, Texas

Director of the Reproductive Endocrinology Service
University of Houston

Disclosure: non-public support of research – Wyeth Laboratories, Warner Chilcott, Duramed.

Disclaimer

This CME activity is designed for use by healthcare professionals for educational purposes only. Information and opinion offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information.

Baylor College of Medicine makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Links are provided to other Internet sites solely for the convenience of users. Once you link to another site, you are subject to the site's terms and conditions of use including copyright and licensing restrictions.

Disclosure

back to top

The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: l) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.

Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.

If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Paula J. Adams Hillard, Contributor: non-public support of research - Berlex, Duramed, Wyeth-Ayerst; speakers bureau member - Association of Reproductive Health Professionals, Barr Labs, Berlex, Merck Pharmaceuticals, Organon, Wyeth-Ayerst; advisory committee member - GlaxoSmithKline, Merck Pharmaceuticals, Procter & Gamble, Wyeth-Ayerst; consultant - GlaxoSmithKline, Merck Pharmaceuticals, Procter & Gamble, Wyeth-Ayerst; honorarium recipient - Association of Reproductive Health Professionals, Barr Labs, Berlex, GlaxoSmithKline, Merck Pharmaceuticals, Organon, Wyeth-Ayerst.

Alfred Poindexter, MD, Activity Director: non-public support of research – Duramed, Wyeth Labs, Warner Chilcott.

The following individual(s) has/have reported no financial or other relationships with commercial entities whose products/services may relate to the educational content of this activity:

Paula Amato, MD, Activity Director and Peer Reviewer: nothing to disclose.

Catherine Stevens-Simon, MD, Contributor:  nothing to disclose.

Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with the applicable law.

Baylor College of Medicine requires that all contributors disclose an unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products, and provide adequate scientific and clinical justification for such use. Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.

Acknowledgement of Support

This CME activity is supported by an educational grant from Wyeth Pharmaceuticals, Inc.

back to top